- Investing Ideas
- /
- Swiss Pharmaceuticals & Biotech Large Cap High Growth Potential
Swiss Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
3
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
3 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SDZ | CHF 43.64 | 1.7% | 52.6% | CHF 19.1b | CHF 44.46 | PS2.1x | E30.0% | 1.0% | ||
GALD | CHF 110.70 | 0.8% | n/a | CHF 26.3b | CHF 101.28 | PS6.7x | E36.4% | n/a | ||
LONN | CHF 582.00 | -1.5% | 35.2% | CHF 42.0b | CHF 647.48 | PE66.1x | E20.9% | 0.7% |
Page 1 of 1